Listen as expert faculty review the latest data and guidelines on patient-centered ART selection for treatment-naive and virologically suppressed patients. Topics include assessing treatment options; individualizing ART for women of childbearing potential and during pregnancy, patients with OIs, and during the COVID-19 pandemic; and new data on investigational ART strategies.
Here’s why patients need to be placed front and center when choosing antiretroviral therapy.
Here’s why I think the 3 most essential aspects when switching ART are treatment history, genetic barrier to resistance, and hearing what your patient is telling you.
Here are my thoughts on how the emergence of long-acting ART reflects the continued evolution of HIV treatment to better meet the broad needs of our patients and what ongoing research efforts may bring about for future long-acting ART options.
How soon should ART be initiated in patients who present with opportunistic infections, and what is the best regimen? In this commentary, I share my approach to starting ART in patients with advanced HIV and opportunistic infections.
Expert-authored slides covering the latest data and guidelines on patient-centered ART selection for treatment-naive and virologically suppressed patients. Topics include assessing treatment options, individualizing ART for women of childbearing potential and during pregnancy, patients with OIs, and during the COVID-19 pandemic, as well as new data on investigational ART strategies.
Hear insights from 3 faculty experts as they present emerging data and guidelines and engage in discussion on patient-centered ART selection for people with HIV.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.